Israel Develops Non-Invasive Brain Test To Help Prevent Alzheimer's
JNN News, August 9, 2019
A new medical test that could help doctors prevent the onset of Alzheimer’s disease – and discover new and better treatments for it – is now being conducted in Israel.
Hadassah-University Medical Center, on Jerusalem’s Mount Scopus, announced that its SRY subsidiary has contracted with General Electric (GE) to be the sole producer of Vizamyl, a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain. It estimates plaque density in adult patients with cognitive impairment, who are being evaluated for Alzheimer’s disease. “If you don’t see any deposit in the brain, you are OK,” explained Dr. Eyal Mishani of the Nuclear Medicine Institute at Hadassah Medical Center. “If you do see some, then you are at risk. You can change your way of living to suspend or prevent the onset of Alzheimer’s or help mitigate the progression of the disease.”
He said that one can eat different foods, and do certain exercises or other types of training to suspend the progression of the disease. The technology was tested during a series of clinical trials at Sheba Medical Center. Mishani is confident that it will eventually be used regularly. Hadassah has a six-year contract to exclusively produce and market the compound. (J. Post)